149 related articles for article (PubMed ID: 28937589)
1. Viral-Cellular DNA Junctions as Molecular Markers for Assessing Intra-Tumor Heterogeneity in Cervical Cancer and for the Detection of Circulating Tumor DNA.
Carow K; Gölitz M; Wolf M; Häfner N; Jansen L; Hoyer H; Schwarz E; Runnebaum IB; Dürst M
Int J Mol Sci; 2017 Sep; 18(10):. PubMed ID: 28937589
[TBL] [Abstract][Full Text] [Related]
2. Detection of integrated papillomavirus sequences by ligation-mediated PCR (DIPS-PCR) and molecular characterization in cervical cancer cells.
Luft F; Klaes R; Nees M; Dürst M; Heilmann V; Melsheimer P; von Knebel Doeberitz M
Int J Cancer; 2001 Apr; 92(1):9-17. PubMed ID: 11279600
[TBL] [Abstract][Full Text] [Related]
3. Human papillomavirus mutational insertion: specific marker of circulating tumor DNA in cervical cancer patients.
Campitelli M; Jeannot E; Peter M; Lappartient E; Saada S; de la Rochefordière A; Fourchotte V; Alran S; Petrow P; Cottu P; Pierga JY; Lantz O; Couturier J; Sastre-Garau X
PLoS One; 2012; 7(8):e43393. PubMed ID: 22937045
[TBL] [Abstract][Full Text] [Related]
4. Comprehensive mapping of the human papillomavirus (HPV) DNA integration sites in cervical carcinomas by HPV capture technology.
Liu Y; Lu Z; Xu R; Ke Y
Oncotarget; 2016 Feb; 7(5):5852-64. PubMed ID: 26735580
[TBL] [Abstract][Full Text] [Related]
5. Frequent genomic structural alterations at HPV insertion sites in cervical carcinoma.
Peter M; Stransky N; Couturier J; Hupé P; Barillot E; de Cremoux P; Cottu P; Radvanyi F; Sastre-Garau X
J Pathol; 2010 Jul; 221(3):320-30. PubMed ID: 20527025
[TBL] [Abstract][Full Text] [Related]
6. Recurrent integration of human papillomaviruses 16, 45, and 67 near translocation breakpoints in new cervical cancer cell lines.
Koopman LA; Szuhai K; van Eendenburg JD; Bezrookove V; Kenter GG; Schuuring E; Tanke H; Fleuren GJ
Cancer Res; 1999 Nov; 59(21):5615-24. PubMed ID: 10554043
[TBL] [Abstract][Full Text] [Related]
7. Loss of gene function as a consequence of human papillomavirus DNA integration.
Schmitz M; Driesch C; Beer-Grondke K; Jansen L; Runnebaum IB; Dürst M
Int J Cancer; 2012 Sep; 131(5):E593-602. PubMed ID: 22262398
[TBL] [Abstract][Full Text] [Related]
8. Quantitative analysis of the relationship between microRNA‑124a, -34b and -203 gene methylation and cervical oncogenesis.
Botezatu A; Goia-Rusanu CD; Iancu IV; Huica I; Plesa A; Socolov D; Ungureanu C; Anton G
Mol Med Rep; 2011; 4(1):121-8. PubMed ID: 21461574
[TBL] [Abstract][Full Text] [Related]
9. Molecular analysis of cellular loci disrupted by papillomavirus 16 integration in cervical cancer: frequent viral integration in topologically destabilized and transcriptionally active chromosomal regions.
Choo KB; Chen CM; Han CP; Cheng WT; Au LC
J Med Virol; 1996 May; 49(1):15-22. PubMed ID: 8732866
[TBL] [Abstract][Full Text] [Related]
10. Human papillomavirus detection in cervical carcinoma tissues and paraaortic lymph nodes by the polymerase chain reaction.
Park JS; Chee YH; Namkoong SE; Han SK; Kim TE; Lee HY; Kim SJ
Gynecol Oncol; 1994 Jun; 53(3):344-51. PubMed ID: 8206408
[TBL] [Abstract][Full Text] [Related]
11. Comparison of oncogenic HPV type-specific viral DNA load and E6/E7 mRNA detection in cervical samples: results from a multicenter study.
Broccolo F; Fusetti L; Rosini S; Caraceni D; Zappacosta R; Ciccocioppo L; Matteoli B; Halfon P; Malnati MS; Ceccherini-Nelli L
J Med Virol; 2013 Mar; 85(3):472-82. PubMed ID: 23280876
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of human papillomavirus-consensus primers for HPV detection by the polymerase chain reaction.
Harnish DG; Belland LM; Scheid EE; Rohan TE
Mol Cell Probes; 1999 Feb; 13(1):9-21. PubMed ID: 10024428
[TBL] [Abstract][Full Text] [Related]
13. Genomic cloning and characterization of the nonoccupied allele corresponding to the integration site of human papillomavirus type 16 DNA in the cervical cancer cell line SiHa.
Bauer-Hofmann R; Borghouts C; Auvinen E; Bourda E; Rösl F; Alonso A
Virology; 1996 Mar; 217(1):33-41. PubMed ID: 8599218
[TBL] [Abstract][Full Text] [Related]
14. Identification of human papillomavirus type 16 integration sites in high-grade precancerous cervical lesions.
Matovina M; Sabol I; Grubisić G; Gasperov NM; Grce M
Gynecol Oncol; 2009 Apr; 113(1):120-7. PubMed ID: 19157528
[TBL] [Abstract][Full Text] [Related]
15. Utilization of the human genome sequence localizes human papillomavirus type 16 DNA integrated into the TNFAIP2 gene in a fatal cervical cancer from a 39-year-old woman.
Einstein MH; Cruz Y; El-Awady MK; Popescu NC; DiPaolo JA; van Ranst M; Kadish AS; Romney S; Runowicz CD; Burk RD
Clin Cancer Res; 2002 Feb; 8(2):549-54. PubMed ID: 11839676
[TBL] [Abstract][Full Text] [Related]
16. Physical status and expression of HPV genes in cervical cancers.
Park JS; Hwang ES; Park SN; Ahn HK; Um SJ; Kim CJ; Kim SJ; Namkoong SE
Gynecol Oncol; 1997 Apr; 65(1):121-9. PubMed ID: 9103401
[TBL] [Abstract][Full Text] [Related]
17. [Detection of physical status of human papillomavirus 16 in cervical cancer tissue and SiHa cell line by multiplex real-time polymerase chain reaction].
Zheng Y; Peng ZL; Lou JY; Wang H
Ai Zheng; 2006 Mar; 25(3):373-7. PubMed ID: 16536998
[TBL] [Abstract][Full Text] [Related]
18. Human papillomavirus DNA in sera of cervical cancer patients as tumor marker.
Widschwendter A; Blassnig A; Wiedemair A; Müller-Holzner E; Müller HM; Marth C
Cancer Lett; 2003 Dec; 202(2):231-9. PubMed ID: 14643453
[TBL] [Abstract][Full Text] [Related]
19. Low incidence of HPV DNA in sera of pretreatment cervical cancer patients.
Liu VW; Tsang P; Yip A; Ng TY; Wong LC; Ngan HY
Gynecol Oncol; 2001 Aug; 82(2):269-72. PubMed ID: 11531278
[TBL] [Abstract][Full Text] [Related]
20. Circulating HPV DNA as a Marker for Early Detection of Relapse in Patients with Cervical Cancer.
Jeannot E; Latouche A; Bonneau C; Calméjane MA; Beaufort C; Ruigrok-Ritstier K; Bataillon G; Larbi Chérif L; Dupain C; Lecerf C; Popovic M; de la Rochefordière A; Lecuru F; Fourchotte V; Jordanova ES; von der Leyen H; Tran-Perennou C; Legrier ME; Dureau S; Raizonville L; Bello Roufai D; Le Tourneau C; Bièche I; Rouzier R; Berns EMJJ; Kamal M; Scholl S
Clin Cancer Res; 2021 Nov; 27(21):5869-5877. PubMed ID: 34210686
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
